A detailed history of Next Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Next Capital Management LLC holds 2,116 shares of ABBV stock, worth $376,669. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,116
Previous 2,301 8.04%
Holding current value
$376,669
Previous $394,000 5.84%
% of portfolio
0.17%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $30,310 - $36,876
-185 Reduced 8.04%
2,116 $417,000
Q2 2024

Aug 20, 2024

SELL
$154.79 - $180.76 $10,835 - $12,653
-70 Reduced 2.95%
2,301 $394,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $60,731 - $69,198
380 Added 19.09%
2,371 $431,000
Q4 2023

Jan 19, 2024

BUY
$137.6 - $154.97 $33,161 - $37,347
241 Added 13.77%
1,991 $308,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $233,782 - $270,637
1,750 New
1,750 $260,000
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $52,281 - $62,698
-378 Reduced 22.33%
1,315 $213,000
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $24,963 - $28,630
186 Added 12.34%
1,693 $227,000
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $963 - $1,224
7 Added 0.47%
1,507 $230,000
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $161,145 - $203,895
1,500 New
1,500 $203,000
Q2 2021

Oct 19, 2021

SELL
$105.21 - $117.21 $199,057 - $221,761
-1,892 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $28,439 - $31,308
-278 Reduced 12.81%
1,892 $205,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $174,663 - $235,813
2,170 New
2,170 $233,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $18,831 - $22,640
-299 Closed
0 $0
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $19,644 - $25,110
299 New
299 $22,000
Q1 2019

Apr 22, 2019

SELL
$77.14 - $90.79 $1,619 - $1,906
-21 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $1,634 - $2,016
21 New
21 $2,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Next Capital Management LLC Portfolio

Follow Next Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Capital Management LLC with notifications on news.